100% of moneycontrol users recommend buying Biocon.
What's your call on Biocon today?
Read 21 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||3200.60||-0.88||3353.85||2420.00||54,527.29|
|Mar' 14||Sep' 13||Jun' 13||Mar' 13|
National Buildings Constr Recommended on Jul 14th 2014
Recommended price 396.00 | Peak from reco 767.50 93.69%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Biocon is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 9,960.00 crore.The company has reported a consolidated sales of Rs 718.81 crore and a Net Profit of Rs 107.17 crore for the quarter ended Jun 2014.
The company management includes Kiran Mazumdar Shaw - Chairperson & Managing Director, John Shaw - Vice Chairman, Arun Chandavarkar - Joint Managing Director & CEO, Charles L Cooney - Director, Mary Harney - Director, Bala S Manian - Director, Ravi Mazumdar - Director, Suresh N Talwar - Director, Peter Bains - Director, Russel Walls - Director, Catherine Rosenberg - Director.
It is listed on the BSE with a BSE Code of 532523 and the NSE with an NSE Code of BIOCON.
Its Registered office is at 20th K M, Hosur Road, Electronic City P O, Bangalore,Karnataka - 560100.
Their Registrars are Karvy Computershare Private Ltd.